Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: An evidence-based review with recommendations

International Forum of Allergy and Rhinology

Volumn 3, Issue 2, 2013, Pages 104-120

  Poetker, David M ^a   Jakubowski, Luke A ^a   Lal, Devyani ^b   Hwang, Peter H ^c   Wright, Erin D ^d   Smith, Timothy L ^e  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Corticosteroids; Evidence based medicine; Nasal polyps; Rhinosinusitis; Sinusitis; Steroids

Indexed keywords

BUDESONIDE; CORTICOSTEROID; DOXYCYCLINE; FLUOCORTOLONE; FLUTICASONE PROPIONATE; FUROSEMIDE; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE; PREDNISONE;

AGGRESSION; BLEEDING; CHRONIC RHINOSINUSITIS; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FOLLOW UP; FUNGAL SINUSITIS; HUMAN; META ANALYSIS; MULTICENTER STUDY (TOPIC); NOSE POLYP; OPERATION DURATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHORT COURSE THERAPY; SIDE EFFECT; SMELLING; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; NASAL POLYPS; RHINITIS; SINUSITIS; TREATMENT OUTCOME;

EID: 84873906403     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21072     Document Type: Review

References (46)

1. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg. 2007;137((3 Suppl):):S1-S31.
2. Dubin MG, Liu C, Lin SY, Senior BA. American Rhinologic Society member survey on "maximal medical therapy" for chronic rhinosinusitis. Am J Rhinol. 2007;21:483-488.
3. Kaszuba SM, Stewart MG. Medical management and diagnosis of chronic rhinosinusitis: a survey of treatment patterns by united states otolaryngologists. Am J Rhinol. 2006;20:186-190.
4. Lal D, Hwang PH. Oral corticosteroid therapy in chronic rhinosinusitis without polyposis: a systematic review. Int Forum Allergy Rhinol. 2011;1:136-143.
5. Martinez-Devesa P, Patiar S. Oral steroids for nasal polyps. Cochrane Database Syst Rev. 2011;(7):CD005232.
6. Hamilos DL. Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol. 2011;128:693-707; quiz 708-709.
7. Chakrabarti A, Denning DW, Ferguson BJ, et al. Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope. 2009;119:1809-1818.
8. Ferguson BJ. Categorization of eosinophilic chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2004;12:237-242.
9. Rudmik L, Smith TL. Development of an evidence-based review with recommendations using an online iterative process. Int Forum Allergy Rhinol. 2011;1:431-437.
10. Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps Group. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology. 2007;45:97-101.
11. Desrosiers M, Evans GA, Keith PK, et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2011;40((Suppl 2):):S99-S193.
12. Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence Working Group. Levels of Evidence 2011. http://www.cebm.net/index.aspx?o=5653. Accessed July 12, 2012.
13. American Academy of Pediatrics Steering Committee on Quality Improvement and Management. Classifying recommendations for clinical practice guidelines. Pediatrics. 2004;114:874-877.
14. Lal D, Scianna JM, Stankiewicz JA. Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure. Am J Rhinol Allergy. 2009;23:396-400.
15. Subramanian HN, Schechtman KB, Hamilos DL. A retrospective analysis of treatment outcomes and time to relapse after intensive medical treatment for chronic sinusitis. Am J Rhinol. 2002;16:303-312.
16. Hessler JL, Piccirillo JF, Fang D, et al. Clinical outcomes of chronic rhinosinusitis in response to medical therapy: results of a prospective study. Am J Rhinol. 2007;21:10-18.
17. Ikeda K, Sakurada T, Suzaki Y, Takasaka T. Efficacy of systemic corticosteroid treatment for anosmia with nasal and paranasal sinus disease. Rhinology. 1995;33:162-165.
18. Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am. 2010;43:753-768.
19. Jankowski R, Bodino C. Olfaction in patients with nasal polyposis: effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalization). Rhinology. 2003;41:220-230.
20. Jankowski R, Bodino C. Evolution of symptoms associated to nasal polyposis following oral steroid treatment and nasalization of the ethmoid-radical ethmoidectomy is functional surgery for NPS. Rhinology. 2003;41:211-219.
21. Vaidyanathan S, Williamson P, Anderson K, Lipworth B. Effect of systemic steroids on humming nasal nitric oxide in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol. 2010;105:412-417.
22. Landsberg R, Segev Y, DeRowe A, Landau T, Khafif A, Fliss DM. Systemic corticosteroids for allergic fungal rhinosinusitis and chronic rhinosinusitis with nasal polyposis: a comparative study. Otolaryngol Head Neck Surg. 2007;136:252-257.
23. Damm M, Jungehulsing M, Eckel HE, Schmidt M, Theissen P. Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging. Otolaryngol Head Neck Surg. 1999;120:517-523.
24. van Camp C, Clement PA. Results of oral steroid treatment in nasal polyposis. Rhinology. 1994;32:5-9.
25. Tuncer U, Soylu L, Aydogan B, Karakus F, Akcali C. The effectiveness of steroid treatment in nasal polyposis. Auris Nasus Larynx. 2003;30:263-268.
26. Rasp G, Kramer MF, Ostertag P, Kastenbauer E. A new system for the classification of ethmoid polyposis. effect of combined local and systemic steroid therapy. Laryngorhinootologie. 2000;79:266-272.
27. Blomqvist EH, Lundblad L, Anggard A, Haraldsson PO, Stjarne P. A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol. 2001;107:224-228.
28. Benítez P, Alobid I, de Haro J, et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope. 2006;116:770-775.
29. Alobid I, Benitez P, Pujols L, et al. Severe nasal polyposis and its impact on quality of life. the effect of a short course of oral steroids followed by long-term intranasal steroid treatment. Rhinology. 2006;44:8-13.
30. Kroflic B, Coer A, Baudoin T, Kalogjera L. Topical furosemide versus oral steroid in preoperative management of nasal polyposis. Eur Arch Otorhinolaryngol. 2006;263:767-771.
31. Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125:1069-1076.e4.
32. Hissaria P, Smith W, Wormald PJ, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006;118:128-133.
33. Vaidyanathan S, Barnes M, Williamson P, Hopkinson P, Donnan PT, Lipworth B. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial. Ann Intern Med. 2011;154:293-302.
34. Kirtsreesakul V, Wongsritrang K, Ruttanaphol S. Clinical efficacy of a short course of systemic steroids in nasal polyposis. Rhinology. 2011;49:525-532.
35. Poetker DM, Smith TL. What rhinologists and allergists should know about the medico-legal implications of corticosteroid use: a review of the literature. Int Forum Allergy Rhinol. 2012;2:95-103.
36. Bent JP 3rd, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1994;111:580-588.
37. Rupa V, Jacob M, Mathews MS, Seshadri MS. A prospective, randomised, placebo-controlled trial of postoperative oral steroid in allergic fungal sinusitis. Eur Arch Otorhinolaryngol. 2010;267:233-238.
38. Ikram M, Abbas A, Suhail A, Onali MA, Akhtar S, Iqbal M. Management of allergic fungal sinusitis with postoperative oral and nasal steroids: a controlled study. Ear Nose Throat J. 2009;88:E8-E11.
39. Woodworth BA, Joseph K, Kaplan AP, Schlosser RJ. Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg. 2004;131:585-589.
40. Giordano J, Darras J, Chevalier D, Mortuaire G. Preoperative corticosteroid treatment and nasal polyposis. Ann Otolaryngol Chir Cervicofac. 2009;126:120-124.
41. Sieskiewicz A, Olszewska E, Rogowski M, Grycz E. Preoperative corticosteroid oral therapy and intraoperative bleeding during functional endoscopic sinus surgery in patients with severe nasal polyposis: a preliminary investigation. Ann Otol Rhinol Laryngol. 2006;115:490-494.
42. Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel perioperative sinus endoscopy (POSE) scoring system. Laryngoscope. 2007;117((11 Pt 2 Suppl 115):):1-28.
43. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg. 1997;117((3 Pt 2):):S1-S7.
44. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129((3 Suppl):):S1-S32.
45. deShazo RD, Swain RE. Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol. 1995;96:24-35.
46. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114((6 Suppl):):155-212.